Oral contraceptives and breast cancer
- PMID: 2713248
- PMCID: PMC2247141
- DOI: 10.1038/bjc.1989.125
Oral contraceptives and breast cancer
Abstract
A population-based case-control study of oral contraceptive use and breast cancer was carried out among young women (less than 43 years of age) at Group Health Cooperative of Puget Sound, Seattle, Washington. Use of oral contraceptives before first pregnancy did not materially differ between cases or controls. The rate ratio estimate of breast cancer incidence in women who had used oral contraceptives before first pregnancy compared to those who had not was 0.9 (95% CI = 0.4, 2.1). There were no meaningful patterns of association between breast cancer and duration of use or formulation of oral contraceptive used before first pregnancy.
PIP: A case-controlled study of the association between oral contraceptive use before pregnancy and breast cancer diagnosed before age 43 was conducted using members of the Group Health Cooperative of Puget Sound, Seattle, Washington. 95 cases were selected from women with tumors diagnosed between July 1978 and December 1983; 136 controls were selected based on duration of membership, and matched for age and duration of membership, and matched for age and duration of membership in the plan. Analytic methods multiple logistic regression; ratio of the rate from coefficients of the logistic regressions; tests for trend were based on comparisons of coefficients to their standard errors using non-categorical models. The occurrence of nulliparity, late age of 1st pregnancy, history of breast lumps, history of maternal cancer and early age of menarche was higher in cases to the extent found in previous studies. Oral contraceptive use was slightly less frequent among cases than controls: 61% vs. 71%, a rate ratio of 0.9 (n.s.) after controlling for age of 1st pregnancy, history of breast lumps, age of menarche and history of maternal cancer. There was no significant difference in total duration of use: the rate ratios were 0.7, 0.7, 1.4 and 1.9 for 1-4 years, 5-9 years, 10+ years and unknown, respectively. The rate ratio for use before 1st pregnancy was 0.9. Age at 1st pregnancy was the strongest confounder in the logistic regression model. Cases and controls did not differ in duration of use before pregnancy: the rate ratios were 0.3, 0.8, 1.3 and 0.3 for 1 year, 1-3 years, 4 or more years or unknown. The test for trend was not significant (p=0.2).
Similar articles
-
Breast cancer among young U.S. women in relation to oral contraceptive use.J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. doi: 10.1093/jnci/86.7.505. J Natl Cancer Inst. 1994. PMID: 8133534
-
Breast cancer before age 45 and oral contraceptive use: new findings.Am J Epidemiol. 1989 Feb;129(2):269-80. doi: 10.1093/oxfordjournals.aje.a115132. Am J Epidemiol. 1989. PMID: 2912040
-
Oral contraceptives and breast cancer.Am J Epidemiol. 1980 Nov;112(5):577-85. doi: 10.1093/oxfordjournals.aje.a113030. Am J Epidemiol. 1980. PMID: 7435486
-
Oral contraceptives and breast cancer.Am J Obstet Gynecol. 1990 Oct;163(4 Pt 2):1379-87. doi: 10.1016/0002-9378(90)91352-d. Am J Obstet Gynecol. 1990. PMID: 2220962 Review.
-
Oral contraceptives and breast cancer: review of the epidemiologic literature.Contraception. 1991 Jun;43(6):597-642. doi: 10.1016/0010-7824(91)90006-2. Contraception. 1991. PMID: 1868735 Review.
Cited by
-
Hormonal content and potency of oral contraceptives and breast cancer risk among young women.Br J Cancer. 2003 Jan 13;88(1):50-7. doi: 10.1038/sj.bjc.6600691. Br J Cancer. 2003. PMID: 12556959 Free PMC article.
-
Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010.Int J Environ Res Public Health. 2021 Apr 27;18(9):4638. doi: 10.3390/ijerph18094638. Int J Environ Res Public Health. 2021. PMID: 33925599 Free PMC article.
-
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.MMWR Recomm Rep. 2024 Aug 8;73(4):1-126. doi: 10.15585/mmwr.rr7304a1. MMWR Recomm Rep. 2024. PMID: 39106314 Free PMC article.
-
The relationship between oral contraceptive use, cancer and vascular disease.Drug Saf. 1990 Nov-Dec;5(6):436-46. doi: 10.2165/00002018-199005060-00004. Drug Saf. 1990. PMID: 2285497 Review.
-
Oral contraceptives and breast cancer.Br J Cancer. 1990 Jan;61(1):1-4. doi: 10.1038/bjc.1990.1. Br J Cancer. 1990. PMID: 2404506 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous